Award
National Institute of Allergy and Infectious Diseases 5R01AI161085-05
Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2
Recipient
Kansas State University
Award Amount
$727,637.00
Ceiling
$727,637.00
Awarded
February 25, 2026
Identifier
5R01AI161085-05
This NIH grant funds research at Kansas State University to develop antiviral therapeutics targeting the 3C-like protease of SARS-CoV-2, aiming to advance protease inhibitors to preclinical drug candidates for COVID-19 treatment.
Description
Research grant for lead optimization of protease inhibitors against SARS-CoV-2 to develop preclinical drug candidates targeting viral 3C-like protease.